Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?

doi:10.1245/s10434-023-14800-w

Back to search

Article

Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?

Annals of surgical oncology - 1 Apr 2024

Polidorio Natália, Montagna Giacomo, Sevilimedu Varadan, Le Tiana, Morrow Monica

Abstract excerpt

BACKGROUND: Breast cancer subtypes, distinguished by hormone receptor (HR) and HER2 status, have different clinicopathologic features. With recognition of the clinical relevance of HER2-low, there is debate as to whether this is a distinct subtype. Our study aimed to determine whether HER2-low br...

Topics

Humans
Female
Receptor, ErbB-2
In Situ Hybridization, Fluorescence
Receptors, Estrogen
Breast Neoplasms
Phenotype

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.